研究:去年第四季中國平板電腦出貨量按年跌5.7% 華為超越蘋果成市場榜首
市場研究機構IDC發表2023年第四季度中國平板電腦季度跟蹤報告,數據顯示,第四季中國平板電腦市場出貨量約817萬部,按年下跌約5.7%,其中消費市場按年下跌7.3%,商用市場按年增長13.8%。
期內,華為超越蘋果(AAPL.US)成為中國平板電腦市場出貨量首位,是自2010年以來首次出現榜首品牌更替。
去年全年中國平板市場出貨量下降4.5%,IDC認為,行業發展勢頭良好,受益於內外因素的正面影響,從市場參與者的變化或從產品出貨量層面,均與疫情時期的行業發展狀況不同,平板電腦正在走出家庭,成為個人移動計算終端之一。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.